Open AccessCase Report of Thymoma Tumor Reduction Following Plasmapheresis
Author(s) -
Wei Jiang,
Yu Qin
Publication year - 2015
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000002173
Subject(s) - thymoma , plasmapheresis , medicine , myasthenia gravis , etiology , thymus neoplasm , chemotherapy , radiation therapy , surgery , immunology , antibody
For thymoma, multidisciplinary antitumor strategy is composed of surgery, chemotherapy, and radiotherapy. Meanwhile, ∼20% to 25% of patients with thymoma have myasthenia gravis and plasmapheresis is recommended for thymoma-associated myasthenia gravis. We report a case that a 40-year-old woman with thymoma experiencing tumor relapse after surgery showed significant response to plasmapheresis. This is the first case of thymoma responded to plasmapheresis, which may guide the study of the etiology and pathogenesis of thymoma.